Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis

European Journal of Preventive Cardiology

Volumn 16, Issue 2, 2009, Pages 188-194

  Metsios, Giorgos S ^a,b,d   Stavropoulos Kalinoglou, Antonios ^a,b,d   Panoulas, Vasileios F ^b   Wilson, Mat ^a   Nevill, Alan M ^a   Koutedakis, Yiannis ^a,d   Kitas, George D ^b,c,d  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d Research Institute in Physical Performance and Rehabilitation   (United States)

Author keywords

cardiovascular disease; cardiovascular risk; exercise; physical activity; rheumatoid arthritis; risk factors

Indexed keywords

ANTIGEN; APOLIPOPROTEIN B; AZATHIOPRINE; C REACTIVE PROTEIN; CHOLESTEROL; CYCLOSPORIN; FIBRINOGEN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; LOW DENSITY LIPOPROTEIN; METHOTREXATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SALAZOSULFAPYRIDINE; STEROID; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; VON WILLEBRAND FACTOR; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENDER; HOMEOSTASIS; HUMAN; IMMOBILIZATION; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SMOKING; SYSTOLIC BLOOD PRESSURE; AGED; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; EXERCISE; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 67449096042     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3283271ceb     Document Type: Article

References (49)

1. Symmons DP. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 2002; 16: 707–722.
2. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, Nevill AM, Douglas KM, Jamurtas A, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis 2007; 66: 1316–1321.
3. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Koutedakis Y, Nevill AM, Douglas KM, et al. New resting energy expenditure prediction equations for patients with rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 500–506.
4. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Koutedakis Y, Kitas GD. Metabolism in patients with rheumatoid arthritis: resting energy expenditure, physical activity and diet-induced thermogenesis. Invited review. Recent Patents Endocr Metabol Immune Drug Discov 2008; 2: 97–102.
5. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 607–613.
6. Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman AJ. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990; 49: 363–369.
7. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481–494.
8. Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1477–1482.
9. Situnayake RD, Kitas G. Dyslipidemia and rheumatoid arthritis. Ann Rheum Dis 1997; 56: 341–342.
10. Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006; 54: 2765–2775.
11. Del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737–2745.
12. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695.
13. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793–801.
14. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 1994; 330: 1549–1554.
15. Noda H, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S, et al. Walking and sports participation and mortality from coronary heart disease and stroke. J Am Coll Cardiol 2005; 46: 1761–1767.
16. Cleroux J, Feldman RD, Petrella RJ. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian hypertension society, Canadian coalition for high blood pressure prevention and control, laboratory centre for disease control at health Canada, heart and stroke foundation of Canada. CMAJ 1999; 160: S21–S28.
17. Senuzun F, Fadiloglu C, Burke LE, Payzin S. Effects of home-based cardiac exercise program on the exercise tolerance, serum lipid values and self-efficacy of coronary patients. Eur J Cardiovasc Prev Rehabil 2006; 13: 640–645.
18. Thompson PD, Crouse SF, Goodpaster B, Kelley D, Moyna N, Pescatello L. The acute versus the chronic response to exercise Med Sci Sports Exerc 2001; 33: S438–S445; discussion S452–S453.
19. Ekdahl C, Broman G. Muscle strength, endurance, and aerobic capacity in rheumatoid arthritis: a comparative study with healthy subjects. Ann Rheum Dis 1992; 51: 35–40.
20. De Jong Z, Munneke M, Zwinderman AH, Kroon HM, Ronday KH, Lems WF, et al. Long term high intensity exercise and damage of small joints in rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1399–1405.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324.
22. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–3167.
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National heart, lung, and blood institute scientific statement. Circulation 2005; 112: 2735–2752.
24. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–1847.
25. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402–2410.
26. Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, et al. Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 1286–1298.
27. Dhawan SS, Quyyumi AA. Rheumatoid arthritis and cardiovascular disease. Curr Atheroscler Rep 2008; 10: 128–133.
28. Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD, et al. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007; 14: 837–843.
29. Evans WJ. Protein nutrition, exercise and aging. J Am Coll Nutr 2004; 23: 601S–609S.
30. Poirier P, Despres JP. Exercise in weight management of obesity. Cardiol Clin 2001; 19: 459–470.
31. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007; 28: 2375–2414.
32. Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15: 254–259.
33. Lau CS, McLaren M, Hanslip J, Kerr M, Belch JJ. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis. Ann Rheum Dis 1993; 52: 643–649.
34. Herbrig K, Haensel S, Oelschlaegel U, Pistrosch F, Foerster S, Passauer J. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 2006; 65: 157–163.
35. Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J, et al. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 1997; 40: 718–722.
36. Lee KW, Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003; 163: 2368–2392.
37. Sixt S, Rastan A, Desch S, Sonnabend M, Schmidt A, Schuler G, et al. Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease. Eur J Cardiovasc Prev Rehabil 2008; 15: 473–478.
38. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98: 2709–2715.
39. Joubert LM, Manore MM. Exercise, nutrition, and homocysteine. Int J Sport Nutr Exerc Metab 2006; 16: 341–361.
40. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381–1395.
41. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, Panoulas VF, et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford) 2007; 46: 1824–1827.
42. Rosemann T, Kuehlein T, Laux G, Szecsenyi J. Factors associated with physical activity of patients with osteoarthritis of the lower limb. J Eval Clin Pract 2008; 14: 288–293.
43. Quinn A, Doody C, O'shea D. The effect of a physical activity education programme on physical activity, fitness, quality of life and attitudes to exercise in obese females. J Sci Med Sport 2008; 11: 469–472.
44. Brodin N, Eurenius E, Jensen I, Nisell R, Opava CH. Coaching patients with early rheumatoid arthritis to healthy physical activity: a multicenter, randomized, controlled study. Arthritis Rheum 2008; 59: 325–331.
45. Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ, Treharne GJ, Panoulas VF, Douglas KM, et al. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology (Oxford) 2008; 47: 239–248.
46. Eurenius E, Stenstrom CH. Physical activity, physical fitness, and general health perception among individuals with rheumatoid arthritis. Arthritis Rheum 2005; 53: 48–55.
47. Leon AS, Connett J, Jacobs DR Jr, Rauramaa R. Leisure-time physical activity levels and risk of coronary heart disease and death. The multiple risk factor intervention trial. JAMA 1987; 258: 2388–2395.
48. Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328: 538–545.
49. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347: 1483–1492.